- Home
- ADTN vs BBNX Comparison
ADTN vs BBNX Comparison
Compare ADTN & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTN
- BBNX
- Stock Information
- Founded
- ADTN 1985
- BBNX 2015
- Country
- ADTN United States
- BBNX United States
- Employees
- ADTN N/A
- BBNX N/A
- Industry
- ADTN Telecommunications Equipment
- BBNX Medical/Dental Instruments
- Sector
- ADTN Telecommunications
- BBNX Health Care
- Exchange
- ADTN Nasdaq
- BBNX Nasdaq
- Market Cap
- ADTN 717.9M
- BBNX 740.7M
- IPO Year
- ADTN 1994
- BBNX 2025
- Fundamental
- Price
- ADTN $10.44
- BBNX $25.31
- Analyst Decision
- ADTN Strong Buy
- BBNX Strong Buy
- Analyst Count
- ADTN 4
- BBNX 10
- Target Price
- ADTN $12.00
- BBNX $24.40
- AVG Volume (30 Days)
- ADTN 748.4K
- BBNX 682.8K
- Earning Date
- ADTN 11-05-2025
- BBNX 11-06-2025
- Dividend Yield
- ADTN N/A
- BBNX N/A
- EPS Growth
- ADTN N/A
- BBNX N/A
- EPS
- ADTN N/A
- BBNX N/A
- Revenue
- ADTN $983,368,000.00
- BBNX $69,830,000.00
- Revenue This Year
- ADTN $17.80
- BBNX $42.80
- Revenue Next Year
- ADTN $8.46
- BBNX $34.58
- P/E Ratio
- ADTN N/A
- BBNX N/A
- Revenue Growth
- ADTN 3.52
- BBNX 38911.17
- 52 Week Low
- ADTN $5.26
- BBNX $8.89
- 52 Week High
- ADTN $12.44
- BBNX $26.66
- Technical
- Relative Strength Index (RSI)
- ADTN 63.77
- BBNX 76.39
- Support Level
- ADTN $9.06
- BBNX $18.12
- Resistance Level
- ADTN $10.64
- BBNX $26.66
- Average True Range (ATR)
- ADTN 0.39
- BBNX 1.38
- MACD
- ADTN 0.10
- BBNX 0.64
- Stochastic Oscillator
- ADTN 87.50
- BBNX 85.37
About ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.